Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | TRDA Entrada Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $5.61 -11.7% | $15.90 -2.5% |
| StockIQ Score | 32F Weak Risk: High | 41D Weak Risk: High |
| Technical | 19F | 36F |
| Fundamental | 30F | 35F |
| Growth | 26F | 50C- |
| Fair Value | 43D | 38F |
| News | 44D | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AAPG outperforms TRDA in most categories. Its investor score (41 vs. 32) and technical score (36 vs. 19) are higher, showing stronger market sentiment and short-term price trends. AAPG also leads in growth (50 vs. 26), indicating faster revenue or earnings expansion. TRDA only excels in valuation (43 vs. 38), suggesting it may be cheaper relative to its metrics. Both share a "WEAK" rating.
